<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02779452</url>
  </required_header>
  <id_info>
    <org_study_id>GDM and neurodevelopment</org_study_id>
    <nct_id>NCT02779452</nct_id>
  </id_info>
  <brief_title>Gestational Diabetes Mellitus and Neurodevelopment in Newborns</brief_title>
  <official_title>Does Brain Functions Depend on Omega 3 Transferred to the Fetus During the Intra Uterine Life ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the feasibility of using a quantitative EEG method
      to evaluate neurodevelopment in newborns and to evaluate whether subtle neurodevelopmental
      deficits can be detected in newborns from mothers with gestational diabetes mellitus (GDM)
      compared to control newborns.

      The second purpose of this study is to determine whether cord blood concentration in
      docosahexaenoic acid (DHA), an omega-3 fatty acid, is similar in neonates of well-controlled
      mothers with gestational diabetes mellitus (GDM) compared to control mothers, and to evaluate
      whether this contributes to neonates neurodevelopment status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Maternal weight is measured close to delivery and BMI is calculated. Birth weight, length,
      head circumference, Apgar score and glycaemia are recorded at birth. An EEG are performed on
      the newborn within 48 hrs after birth.A maternal blood sample is collected at admission to
      measure maternal glycated hemoglobin (A1C). Cord blood samples are collected in the umbilical
      vein after delivery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in neurodevelopment</measure>
    <time_frame>At birth</time_frame>
    <description>Evaluate change in neurodevelopment with GDM</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in DHA level in cord blood</measure>
    <time_frame>At birth</time_frame>
    <description>Evaluate change in DHA level with GDM</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">46</enrollment>
  <condition>Diabetes, Gestational</condition>
  <condition>Glucose Metabolism Disorders</condition>
  <arm_group>
    <arm_group_label>GDM newborns</arm_group_label>
    <description>Newborns from gestational diabetes mellitus pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No GDM newborns</arm_group_label>
    <description>Newborn from a normal pregnancy</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      cord blood plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women with singleton pregnancy were recruited in the Centre Hospitalier
        Universitaire de Sherbrooke (CHUS) at 24 - 28 weeks of gestation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  singleton pregnancy

          -  aged between 18 and 40 years

        Exclusion Criteria:

          -  smoking,

          -  illicit drug consumption,

          -  omega-3/6 consumption,

          -  liver or renal disease,

          -  cancer

          -  any medical conditions affecting glucose/lipid metabolism.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mélanie Plourde, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2016</study_first_posted>
  <last_update_submitted>May 18, 2016</last_update_submitted>
  <last_update_submitted_qc>May 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Mélanie Plourde</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>neurodevelopment</keyword>
  <keyword>electroencephalography</keyword>
  <keyword>gestational diabetes mellitus</keyword>
  <keyword>omega 3 polyunsaturated fatty acids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

